Article
UBE2S promotes 5-fluorouracil resistance in colorectal cancer by activating non-canonical NF-κB/TYMS/TK1 signaling
2026-08-10
Abstract excerpt
<b>Background and Purpose: </b>Chemoresistance to 5-fluorouracil (5-FU) remains a formidable barrier in colorectal cancer (CRC) treatment, largely driven by the metabolic rewiring of pyrimidine synthesis. We investigated the role of the ubiquitin-conjugating enzyme E2S (UBE2S) as a master regulator of this resistance phenotype. <b>Experimental Approach: </b>A 5-FU-resistant HCT116 cell model (HCT116R) was establis...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d3f61ece-b12a-580c-80d7-4976b718e219
- DOI
- 10.22541/authorea.15007246/v1
